JP Power shares rally over 17% on Adani bid buzz for JP Associates
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Shares of Jaiprakash Power Ventures JP Power ) surged over 17% to Rs 22.25 in Monday's intraday trade on the BSE, following media reports that the Adani Group has emerged as the highest bidder to acquire Jaiprakash Associates JP Associates ).In June, it was reported that debt-laden Jaiprakash Associates (JAL) had received six resolution plans from suitors including Adani Group, Vedanta JSPL (Naveen Jindal), Suraksha Group, Dalmia Bharat, and PNC Infratech , according to sources. The bids, submitted on June 24, were aimed at acquiring the company in its entirety.JP Associates, which operates across real estate, cement, hospitality, and construction, was admitted into the Corporate Insolvency Resolution Process (CIRP) by the National Company Law Tribunal (NCLT), Allahabad Bench, via an order dated 3 June 2024.The company entered insolvency after defaulting on loan repayments, with total claims from creditors amounting to a staggering Rs 57,185 crore.JP Power has provided a corporate guarantee for a $150 million external commercial borrowing availed by JP Associates from the State Bank of India , which has since been converted into a rupee term loan.JP Power reported a 73% year-on-year decline in net profit to Rs 155.67 crore for the March 2025 quarter, impacted by lower income. In the same quarter last year, the company had posted a net profit of Rs 588.79 crore.Revenue also fell to Rs 1,366.67 crore, down from Rs 1,863.63 crore in the year-ago period. For FY25, net profit dropped to Rs 813.55 crore from Rs 1,021.95 crore in FY24.On the technical charts, JP Power is exhibiting strong bullish momentum . The Relative Strength Index (RSI-14) stands at 69.5, nearing the overbought zone. An RSI above 70 typically signals a possible pullback.The stock is also trading above all eight key Simple Moving Averages (SMAs) — from the 5-day to the 200-day — indicating broad-based strength and sustained upward trend.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
22 minutes ago
- Business Standard
Tier 2 cities outpace metros in residential plot launches: PropEquity
Tier 2 cities such as Indore, Nagpur and Surat have outpaced big cities as realtors launched nearly 470,000 residential plots, with an estimated launch value of approximately Rs 2.44 trillion, across the top 10 tier 1 and tier 2 cities between 2022 and May 2025, according to a report by real estate analytics firm PropEquity. The report stated that seven of the top 10 cities were tier 2, supplying around 243,000 residential plots and accounting for 52 per cent of the total supply. These cities include Indore, Nagpur, Jaipur, Coimbatore, Mysore, Raipur and Surat. On the other hand, only three tier 1 cities — Hyderabad, Bengaluru and Chennai — made it to the top 10, supplying nearly 225,000 residential plots or 48 per cent of the supply share. 'Residential plots have emerged as a safe haven for investors looking at them for self-use or investment post-pandemic owing to their liquidity, faster appreciation and desire to customise their living space,' he added. For developers, Jasuja said plots generate quicker cash flow as they involve faster sales and lower upfront investment compared to apartments. The report further highlighted that in the first five months of 2025, developers launched 45,591 residential plots — 36 per cent of the supply seen in 2024 and 28 per cent of the supply in 2023. In 2024, the supply of residential plots in the top 10 tier 1 and tier 2 cities fell 23 per cent year-on-year (YoY) to 126,556 plots from 163,529 plots in 2023. The weighted average launch price of residential plots in these cities rose 27 per cent YoY in 2024 to Rs 3,679 per square foot.
Indian Express
23 minutes ago
- Indian Express
Theobroma patisserie chain, built by Mumbai-based sisters, eyes Rs 2,410 crore deal with ChrysCapital
Pan-India patisserie chain Theobroma, founded by Mumbai-based sisters Kainaz Messman Harchandrai and Tina Messman Wykes, is likely to be acquired by private equity firm ChrysCapital for Rs 2,410 crore. According to The Economic Times, the homegrown private equity firm will reportedly purchase nearly 90 per cent of the company from its founding promoters, the Wykes family, and existing investor ICICI Venture. The remaining 10 per cent stake is expected to remain with the current shareholders. Born in a small kitchen in Colaba at a neighbour's request, Theobroma — Greek for 'Food of the Gods' — was founded in 2004 by the two sisters. It began as a modest café with just four tables in Mumbai's Colaba and has since grown into a leading patisserie chain with presence in over 30 cities across India. What makes Theobroma's journey exciting is the fact that it is a story of a family coming together and turning their dreams into reality. Kainaz, often described as the soul of Theobroma, began baking as a child, helping her mother, who ran a home-bakery called Not Just Desserts. A trip to France at 16 proved to be a turning point, inspiring her to pursue the culinary arts. She later graduated from Institute of Hotel Management (IHM) Mumbai and the Oberoi Centre of Learning and Development (OCLD) in Delhi, and went on to work as a pastry chef at the Oberoi Udaivilas. In 2004, she launched Theobroma as a cosy neighbourhood coffee shop in Colaba. The second outlet opened in Bandra in 2010 — and the rest, as they say, is history. Today, Theobroma is a household name, with its signature brownies becoming a mainstay across India.
Business Standard
27 minutes ago
- Business Standard
Indices trade with decent gains; pharma shares rally for 3rd day
The headline equity benchmarks traded with modest gains in mid-afternoon trade, extending their upward momentum on the back of sustained buying interest. Investor focus remained on domestic macroeconomic indicators, global tariff-related cues, and corporate earnings announcements. The Nifty traded above the 25,150 mark. Pharma shares extending gains for third day in a row. At 14:26 IST, the barometer index, the S&P BSE Sensex advanced 301.97 points or 0.37% to 82,556.01. The Nifty 50 index added 100.45 points or 0.40% to 25,184.35. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.60% and the S&P BSE Small-Cap index added 0.99%. The market breadth was strong. On the BSE, 2,570 shares rose and 1,392 shares fell. A total of 177 shares were unchanged. Economy: Indias retail inflation, measured by the Consumer Price Index (CPI), cooled to a multi-year low of 2.10% in June 2025, thanks to a sharp dip in food prices. The data, released by the Ministry of Statistics and Programme Implementation (MoSPI) on Monday, 14 July 2025, marks the lowest year-on-year inflation rate since January 2019. For comparison, CPI inflation stood at 2.82% in May 2025 and 5.08% in June 2024. Buzzing Index: The Nifty Pharma index jumped 0.95% to 22,624.25. The index rallied 2.47% in three consecutive trading sessions. Natco Pharma (up 3.04%), Biocon (up 2.84%), Sun Pharmaceutical Industries (up 2.77%), Lupin (up 1.60%), Alkem Laboratories (up 1.45%), Torrent Pharmaceuticals (up 1.15%), Granules India (up 1.14%), Aurobindo Pharma (up 0.95%), Ipca Laboratories (up 0.91%) and Gland Pharma (up 0.68%) advanced. On the other hand, Mankind Pharma (down 1.78%), Divis Laboratories (down 0.32%) and Laurus Labs (down 0.08%) edged lower. Numbers to Track: The yield on India's 10-year benchmark federal paper rose 0.06% to 6.315 from the previous close of 6.311. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 85.8050 compared with its close of 85.9200 during the previous trading session. MCX Gold futures for 5 August 2025 settlement rose 0.16% to Rs 97,931. The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.11% to 97.66. The United States 10-year bond yield fell 0.25% to 4.418. In the commodities market, Brent crude for September 2025 settlement declined 46 cents or 0.66% to $68.75 a barrel. Stocks in Spotlight: Swaraj Engines surged 9.80% after the company reported a 15.7% increase in net profit to Rs 49.97 crore on a 15.8% increase in net operating revenue to Rs 484.10 crore in Q1 FY26 as compared with Q1 FY25.
